![](/img/cover-not-exists.png)
CC4 COST-EFFECTIVENESS ANALYSIS OF PERTUZUMAB WITH TRASTUZUMAB AND CHEMOTHERAPY COMPARED TO TRASTUZUMAB AND CHEMOTHERAPY IN THE ADJUVANT TREATMENT FOR PATIENTS WITH HER2-POSITIVE EARLY BREAST CANCER AT HIGH RISK OF RECURRENCE IN CHINA
Guan, X., Li, H., Chen, Q., Hao, C., Li, J., Wang, Y., Zhang, J., Xu, H., Liu, C., Chu, Y., Ma, A.Volume:
22
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.09.048
Date:
November, 2019
File:
PDF, 595 KB
2019